These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16982862)

  • 1. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease.
    Oikawa T; Kamimura Y; Akiba H; Yagita H; Okumura K; Takahashi H; Zeniya M; Tajiri H; Azuma M
    J Immunol; 2006 Oct; 177(7):4281-7. PubMed ID: 16982862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
    Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
    Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
    Zhang Y; Shlomchik WD; Joe G; Louboutin JP; Zhu J; Rivera A; Giannola D; Emerson SG
    J Immunol; 2002 Dec; 169(12):7111-8. PubMed ID: 12471148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIM-3: a novel regulatory molecule of alloimmune activation.
    Boenisch O; D'Addio F; Watanabe T; Elyaman W; Magee CN; Yeung MY; Padera RF; Rodig SJ; Murayama T; Tanaka K; Yuan X; Ueno T; Jurisch A; Mfarrej B; Akiba H; Yagita H; Najafian N
    J Immunol; 2010 Nov; 185(10):5806-19. PubMed ID: 20956339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Kaneyama T; Tomiki H; Tsugane S; Inaba Y; Ichikawa M; Akiba H; Yagita H; Kim BS; Koh CS
    Int Immunol; 2014 Jul; 26(7):369-81. PubMed ID: 24486565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.
    Liu Y; Ji H; Zhang Y; Shen X; Gao F; He X; Li GA; Busuttil RW; Kuchroo VK; Kupiec-Weglinski JW
    J Hepatol; 2015 Mar; 62(3):563-72. PubMed ID: 25450716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.
    Nagahara K; Arikawa T; Oomizu S; Kontani K; Nobumoto A; Tateno H; Watanabe K; Niki T; Katoh S; Miyake M; Nagahata S; Hirabayashi J; Kuchroo VK; Yamauchi A; Hirashima M
    J Immunol; 2008 Dec; 181(11):7660-9. PubMed ID: 19017954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases.
    Nozawa K; Ohata J; Sakurai J; Hashimoto H; Miyajima H; Yagita H; Okumura K; Azuma M
    J Immunol; 2001 Nov; 167(9):4981-6. PubMed ID: 11673505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance.
    Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
    J Immunol; 2001 May; 166(9):5619-28. PubMed ID: 11313402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.
    Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of donor CD4 and CD8 cells to liver injury during murine graft-versus-host disease.
    Li J; Helm K; Howell CD
    Transplantation; 1996 Dec; 62(11):1621-8. PubMed ID: 8970618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
    Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
    J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyric acid derivative induces allospecific T cell anergy and prevents graft-versus-host disease.
    Gilbert KM; Boger S; Fifer EK
    Immunopharmacol Immunotoxicol; 2003 Feb; 25(1):13-27. PubMed ID: 12675196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.
    Veenstra RG; Taylor PA; Zhou Q; Panoskaltsis-Mortari A; Hirashima M; Flynn R; Liu D; Anderson AC; Strom TB; Kuchroo VK; Blazar BR
    Blood; 2012 Jul; 120(3):682-90. PubMed ID: 22677125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of CTLA-4 signals inhibits Th2-mediated murine chronic graft-versus-host disease by an enhanced expansion of regulatory CD8+ T cells.
    Sakurai J; Ohata J; Saito K; Miyajima H; Hirano T; Kohsaka T; Enomoto S; Okumura K; Azuma M
    J Immunol; 2000 Jan; 164(2):664-9. PubMed ID: 10623808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner.
    Uchida Y; Ke B; Freitas MC; Yagita H; Akiba H; Busuttil RW; Najafian N; Kupiec-Weglinski JW
    Gastroenterology; 2010 Dec; 139(6):2195-206. PubMed ID: 20637206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer.
    Guo Z; Cheng D; Xia Z; Luan M; Wu L; Wang G; Zhang S
    J Transl Med; 2013 Sep; 11():215. PubMed ID: 24044888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.
    Soloviova K; Puliaiev M; Haas M; Dalgard CL; Schaefer BC; Via CS
    J Immunol; 2015 Oct; 195(7):2985-3000. PubMed ID: 26320249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.